Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

Sojo now focuses on the development of business-to-business propositions and is adopting an in-house operations model.

Despite its popularity on TikTok, scalp oiling is nothing new ... Dr. Kopelman explains that this could be in part owing to pumpkin seed oil’s role as a dihydrotestosterone blocker ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

I broke its neck. When making a vase at the potter’s wheel, I torqued its slippery neck clear off the pot as I tried to thin ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

But just when we thought it was officially buried in the style graveyard, the side parting is making a quiet, yet undeniable ...

One subject demonstrating reasonably averaged flexion–extension muscle activity phased with head acceleration data and upper torso kinematics was used to validate a biofidelic 50th percentile human ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

SpotDraft’s software includes AI-assisted redlining tools, which is the process of editing a contract where two or more ...